54.92 USD
-0.17 (-0.31%)
54.93 USD
+0.01 (+0.02%)
We assign a fundamental rating of 5 out of 10 to MDLZ. MDLZ was compared to 87 industry peers in the Food Products industry. While MDLZ belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MDLZ does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year MDLZ was profitable.
In the past year MDLZ had a positive cash flow from operations.
Each year in the past 5 years MDLZ has been profitable.
Each year in the past 5 years MDLZ had a positive operating cash flow.
1.2 Ratios
MDLZ has a Return On Assets of 4.95%. This is in the better half of the industry: MDLZ outperforms 74.71% of its industry peers.
MDLZ's Return On Equity of 13.49% is amongst the best of the industry. MDLZ outperforms 82.76% of its industry peers.
MDLZ's Return On Invested Capital of 6.25% is fine compared to the rest of the industry. MDLZ outperforms 67.82% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MDLZ is significantly below the industry average of 27.80%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROIC | 6.25% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
MDLZ's Profit Margin of 9.38% is amongst the best of the industry. MDLZ outperforms 87.36% of its industry peers.
MDLZ's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.59%, MDLZ is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
In the last couple of years the Operating Margin of MDLZ has grown nicely.
With a decent Gross Margin value of 31.05%, MDLZ is doing good in the industry, outperforming 70.11% of the companies in the same industry.
In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
MDLZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, MDLZ has less shares outstanding
Compared to 5 years ago, MDLZ has less shares outstanding
MDLZ has a better debt/assets ratio than last year.
2.2 Solvency
MDLZ has an Altman-Z score of 2.25. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
MDLZ has a Altman-Z score of 2.25. This is comparable to the rest of the industry: MDLZ outperforms 48.28% of its industry peers.
MDLZ has a debt to FCF ratio of 9.31. This is a negative value and a sign of low solvency as MDLZ would need 9.31 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 9.31, MDLZ is doing good in the industry, outperforming 60.92% of the companies in the same industry.
MDLZ has a Debt/Equity ratio of 0.76. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio (0.76) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Altman-Z | 2.25 |
ROIC/WACC0.84
WACC7.45%
2.3 Liquidity
MDLZ has a Current Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ's Current ratio of 0.61 is on the low side compared to the rest of the industry. MDLZ is outperformed by 88.51% of its industry peers.
A Quick Ratio of 0.37 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ has a Quick ratio of 0.37. This is amonst the worse of the industry: MDLZ underperforms 82.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
The earnings per share for MDLZ have decreased strongly by -21.70% in the last year.
The Earnings Per Share has been growing slightly by 6.91% on average over the past years.
MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 4.13%.
Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.09% on average per year.
EPS 1Y (TTM)-21.7%
EPS 3Y6.45%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
3.2 Future
Based on estimates for the next years, MDLZ will show a small growth in Earnings Per Share. The EPS will grow by 3.92% on average per year.
Based on estimates for the next years, MDLZ will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y-14.33%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
EPS Next 5Y3.92%
Revenue Next Year4.87%
Revenue Next 2Y4.39%
Revenue Next 3Y4.16%
Revenue Next 5Y3.83%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.27, MDLZ is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of MDLZ is on the same level as its industry peers.
MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.25.
The Price/Forward Earnings ratio is 17.13, which indicates a rather expensive current valuation of MDLZ.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than 63.22% of the companies in the same industry.
MDLZ is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.27 | ||
| Fwd PE | 17.13 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDLZ is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.95 | ||
| EV/EBITDA | 15.51 |
4.3 Compensation for Growth
The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.79
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.70%, MDLZ has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.47, MDLZ pays a bit more dividend than its industry peers.
MDLZ's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
5.2 History
The dividend of MDLZ is nicely growing with an annual growth rate of 10.52%!
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
69.92% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
54.92
-0.17 (-0.31%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners89.35%
Inst Owner Change-0.09%
Ins Owners0.15%
Ins Owner Change0%
Market Cap70.87B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts78.24
Price Target69.55 (26.64%)
Short Float %2.46%
Short Ratio3.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-0.75%
PT rev (3m)-7.16%
EPS NQ rev (1m)-0.42%
EPS NQ rev (3m)-15.52%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)-4.16%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-1.65%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.27 | ||
| Fwd PE | 17.13 | ||
| P/S | 1.88 | ||
| P/FCF | 30.95 | ||
| P/OCF | 19.82 | ||
| P/B | 2.71 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.51 |
EPS(TTM)2.85
EY5.19%
EPS(NY)3.21
Fwd EY5.84%
FCF(TTM)1.77
FCFY3.23%
OCF(TTM)2.77
OCFY5.05%
SpS29.17
BVpS20.29
TBVpS-13.7
PEG (NY)N/A
PEG (5Y)2.79
Graham Number36.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROCE | 8.75% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 45.17% | ||
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% | ||
| FCFM | 6.08% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 96.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 64.85% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 2.25 |
F-Score5
WACC7.45%
ROIC/WACC0.84
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.45%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-14.33%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year4.87%
Revenue Next 2Y4.39%
Revenue Next 3Y4.16%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year6.67%
EBIT Next 3Y6.61%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 5 / 10 to MDLZ.
Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a valuation rating of 3 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Overvalued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for MDLZ stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 19.27 and the Price/Book (PB) ratio is 2.71.
Can you provide the dividend sustainability for MDLZ stock?
The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 69.92%.